Company intelligence / Profile preview

Heyl Chemisch-pharmazeutische Fabrik

Berlin, Berlin, Germanyheyl.net ↗

Ownership: Private
Development stage: Other

Overview

Heyl is an independent German pharmaceutical company specializing in the development, manufacturing, and global distribution of antidotes for heavy metal and radionuclide poisonings. The company also markets therapeutics for rare diseases such as Wilson’s disease and offers products for rheumatoid arthritis, toxoplasmosis, and vitamin deficiencies. Its products are widely used worldwide due to their unique medical importance.

Therapeutic areas: Metabolic DisordersImmunologyRare DiseasesOtherInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

Dimaval

Partnerships

Collaborations with national/international research institutions and universities

Beyond the preview

Go deeper on Heyl Chemisch-pharmazeutische Fabrik.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heyl Chemisch-pharmazeutische Fabrik.

Explore the full profile